Jane Street Group, LLC Day One Biopharmaceuticals, Inc. Transaction History
Jane Street Group, LLC
- $445 Billion
- Q3 2024
A detailed history of Jane Street Group, LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 69,757 shares of DAWN stock, worth $851,732. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,757
Previous 179,784
61.2%
Holding current value
$851,732
Previous $2.48 Million
60.8%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding DAWN
# of Institutions
181Shares Held
84.2MCall Options Held
148KPut Options Held
218K-
Ra Capital Management, L.P. Boston, MA7.87MShares$96.1 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$78.5 Million11.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$71.9 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$59.5 Million1.92% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$55.4 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $897M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...